Conference item
A brain metastasis therapy tweak, for the better? Concomitant stereotactic radiotherapy and molecular-targeted therapy
- Abstract:
-
The most common cause of cancer demise is the metastasis to distant organs. In particular, brain metastasis represents one of the highest mortality rates in the oncology field. Some of the reasons for the meagre advance in the treatment of this disease are the limited conditions for favourable surgical debulking of tumour, off-target effects of conventional treatments and the limited efficacy of delivery into the brain for currently available drugs. Contrary to those conventional strategies, ...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Accepted manuscript, pdf, 212.0KB)
-
- Publisher copy:
- 10.1093/neuonc/now292.008
Authors
Bibliographic Details
- Publisher:
- Oxford University Press Publisher's website
- Journal:
- 2016 British Neuro-Oncology Society Meeting (BNOS 2016) Journal website
- Volume:
- 19
- Pages:
- 126
- Host title:
- Neuro-Oncology
- Publication date:
- 2017-03-02
- Acceptance date:
- 2016-06-27
- DOI:
- EISSN:
-
1523-5866
- ISSN:
-
1522-8517
- Source identifiers:
-
719630
Item Description
- Pubs id:
-
pubs:719630
- UUID:
-
uuid:41a21992-b867-4671-a907-3a77bdc09c9c
- Local pid:
- pubs:719630
- Deposit date:
- 2018-10-30
Terms of use
- Copyright holder:
- Soto et al
- Copyright date:
- 2017
- Notes:
- © The Author(s) 2017. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. This abstract was presented at the 2016 British Neuro-Oncology Society Meeting (BNOS 2016). This is the accepted manuscript version of the abstract. The final version is available online from Oxford University Press at: https://doi.org/10.1093/neuonc/now292.008
If you are the owner of this record, you can report an update to it here: Report update to this record